MCAGU — Mountain Crest Acquisition V Share News
0.000.00%
FinancialsBalancedMicro Cap
Brief: SPAC Mountain Crest Acquisition Corp V Receives Deficiency Notification From Nasdaq On Delayed Filing Of Annual Report, Quarterly Report
Brief: Cubebio Enter Terms Of Potential Business Combination With Mountain Crest Acquisition Corp
Brief: Mountain Crest Acquisition Corp V Got Letter From Nasdaq
Brief: Mountain Crest Acquisition Corp V Says On June 27, Co Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Mountain Crest Acquisition Receives Termination Notice From AUM Biosciences PTE
Brief: AUM Biosciences Doses First Patient In Phase 2 Clinical Trial Of Aum001 In Metastatic Colorectal Cancer
Brief: Mountain Crest Acquisition Corp V Says On April 3 Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Mountain Crest AUM Biosciences, AUM's Units In Amendment To Merge
Brief: Mountain Crest Acquisition Corp V - On Feb 10 Co, Holdco, Amalgamation Sub, And Merger Sub Entered Into Amendment To Business Combination Agreement
Brief: AUM Biosciences Receives FDA Orphan Drug Designation For Aum302 For The Treatment Of Neuroblastoma
Brief: AUM Biosciences Receives Human Research Ethics Committee Approval To Commence Phase 2 Clinical Trial Of AUM001 For Treatment Of Metastatic Colorectal Cancer In Australia
Brief: AUM Biosciences Announces Plans To Become A Public Company Via Merger With Mountain Crest Acquisition Corp. V
NASDAQ RESUMED AT 10:13 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:09 AM
NASDAQ RESUMED AT 10:08 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:03 AM
Brief: Mountain Crest Acquisition Corp V Closes $60 Mln IPO
NASDAQ RESUMED AT 12:25 PM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM